- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1749-0774
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
mTOR inhibitor everolimus reduces invasiveness of melanoma cells ; volume:33 ; number:1 ; day:4 ; month:10 ; year:2019 ; pages:88-97 ; date:1.2020
Human cell ; 33, Heft 1 (4.10.2019), 88-97, 1.2020
- Urheber
-
Ciołczyk-Wierzbicka, Dorota
Gil, Dorota
Zarzycka, Marta
Laidler, Piotr
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13577-019-00270-4
- URN
-
urn:nbn:de:101:1-2020042005372131582920
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ciołczyk-Wierzbicka, Dorota
- Gil, Dorota
- Zarzycka, Marta
- Laidler, Piotr
- SpringerLink (Online service)
Ähnliche Objekte (12)
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Bacterial invasiveness
The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Bacterial invasiveness
The mTOR Inhibitor Everolimus Attenuates the Time Course of Chronic Anti-Thy1 Nephritis in the Rat
mTOR inhibitor Everolimus-induced apoptosis in melanoma cells
Zelltod-Regulation durch mTOR Inhibitor Everolimus im Nierenzellkarzinom
Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
Everolimus as an mTOR Inhibitor Suppresses Endometriotic Implants: an Experimental Rat Study
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Systems analysis identifies miR-29b regulation of invasiveness in melanoma
The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
Bacterial invasiveness